3,164
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer

ORCID Icon, ORCID Icon & ORCID Icon
Article: 1809083 | Received 07 Jul 2020, Accepted 06 Aug 2020, Published online: 20 Aug 2020

References

  • Howell JB, Altounyan RE. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. The Lancet. 1967 Sep 9;290(7515):539–6.
  • Sinniah A, Yazid S, Flower RJ. The Anti-allergic Cromones: past, Present, and Future. Front Pharmacol. 2017;8:827.
  • Murphy S. Cromolyn sodium: basic mechanisms and clinical usage. Drug Intell Clin Pharm. 1987 Jan;21(1 Pt 1):22–35.
  • Shapiro GG, König P. Cromolyn sodium: a review. Pharmacotherapy. 1985 May-Jun;5(3):156–170.
  • Brogden RN, Speight TM, Avery GS. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs. 1974;7(3):164–282.
  • Hoag JE, McFadden ER Jr. Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy. 1991 Jan;66(1):53–63.
  • Morton AR, Ogle SL, Fitch KD. Effects of nedocromil sodium, cromolyn sodium, and a placebo in exercise-induced asthma. Ann Allergy. 1992 Feb;68(2):143–148.
  • Dixon M, Jackson DM, Richards IM. The Action of Sodium Cromoglycate on ‘C’ Fibre Endings in the Dog Lung. Br J Pharmacol. 1980 Sep;70(1):11–13.
  • Walker SR, Evans ME, Richards AJ, et al. The Fate of (14 C)disodium Cromoglycate in Man. J Pharm Pharmacol. 1972 Jul;24(7):525–531.
  • Aswania OA, Corlett SA, Chrystyn H. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion. Br J Clin Pharmacol. 1999 Jun;47(6):613–618.
  • Keller M, Schierholz J. Have inadequate delivery systems hampered the clinical success of inhaled disodium cromoglycate? Time for reconsideration. Expert Opin Drug Deliv. 2011 Jan;8(1):1–17.
  • Birring SS, Wijsenbeek MS, Agrawal S, et al. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. Lancet Respir Med. 2017 Oct;5(10):806–815.
  • Moroni M, Porta C, Gualtieri G, et al. Inhaled Sodium Cromoglycate to Treat Cough in Advanced Lung Cancer Patients. Br J Cancer. 1996 Jul;74(2):309–311.
  • Pham S, Ferguson GT, Kerwin E, et al. In Vitro Characterization of the eFlow Closed System Nebulizer With Glycopyrrolate Inhalation Solution. J Aerosol Med Pulm Drug Deliv. 2018 Jun;31(3):162–169.
  • Knoch M, Keller M. The customized electronic nebulizer: a new category of liquid aerosol drug delivery systems. Exp Opin Drug Deliv. 2005;2:377–390.
  • Sands D, Sapiejka E, Gąszczyk G, et al. T100 Study Group.Comparison of two tobramycin nebuliser solutions: pharmacokinetic, efficacy and safety profiles of T100 and TNS. J Cyst Fibros. 2014 Dec;13(6):653–660.